Company Overview of Proacta, Inc.
Proacta, Inc., a biopharmaceutical company, engages in the development and commercialization of hypoxia-activated oncology drugs. It offers PR104, a hypoxia-selective small-molecule prodrug that is designed to improve the outcome of cancer patients by targeting cancer cells resistant to current treatments. Proacta, Inc. was incorporated in 2004 and is based in San Diego, California.
4275 Executive Square
San Diego, CA 92037
Founded in 2004
Key Executives for Proacta, Inc.
Similar Private Companies By Industry
|Io Therapeutics, Inc.||United States|
|Antyra, Inc.||United States|
|Cenomed, Inc.||United States|
|E-SCRIPTS.MD, L.L.C.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Proacta, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.